Your browser doesn't support javascript.
loading
Biallelic deletion of 1p32 defines ultra-high-risk myeloma, but monoallelic del(1p32) remains a strong prognostic factor.
Schavgoulidze, Anaïs; Talbot, Alexis; Perrot, Aurore; Cazaubiel, Titouan; Leleu, Xavier; Manier, Salomon; Buisson, Laure; Mahéo, Sabrina; Do Souto Ferreira, Laura; Pavageau, Luka; Hulin, Cyrille; Marolleau, Jean-Pierre; Voillat, Laurent; Belhadj, Karim; Divoux, Marion; Slama, Borhane; Brechignac, Sabine; Macro, Margaret; Stoppa, Anne-Marie; Sanhes, Laurence; Orsini-Piocelle, Frédérique; Fontan, Jean; Chretien, Marie-Lorraine; Demarquette, Hélène; Mohty, Mohamad; Avet-Loiseau, Hervé; Corre, Jill.
Afiliación
  • Schavgoulidze A; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France.
  • Talbot A; Hematology Department, Saint-Louis University Hospital, University of Paris, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Perrot A; Hematology Department, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse, France.
  • Cazaubiel T; Hematology Department, Bordeaux University Hospital, Bordeaux, France.
  • Leleu X; Hematology Department, Poitiers University Hospital, Poitiers, France.
  • Manier S; Hematology Department, Lille University Hospital, Lille, France.
  • Buisson L; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France.
  • Mahéo S; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France.
  • Do Souto Ferreira L; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France.
  • Pavageau L; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France.
  • Hulin C; Hematology Department, Bordeaux University Hospital, Bordeaux, France.
  • Marolleau JP; Hematology Department, Amiens University Hospital, Amiens, France.
  • Voillat L; Hematology Department, Chalon-sur-Saône Hospital, Chalon-sur-Saône, France.
  • Belhadj K; Hematology Department, Créteil University Hospital, Créteil, France.
  • Divoux M; Hematology Department, Nancy University Hospital, Nancy, France.
  • Slama B; Hematology Department, Avignon Hospital, Avignon, France.
  • Brechignac S; Hematology Department, Bobigny University Hospital, Bobigny, France.
  • Macro M; Hematology Department, Caen University Hospital, Caen, France.
  • Stoppa AM; Hematology Department, Institut Paoli Calmettes, Marseille, France.
  • Sanhes L; Hematology Department, Perpignan Hospital, Perpignan, France.
  • Orsini-Piocelle F; Hematology Department, Annecy Hospital, Annecy, France.
  • Fontan J; Hematology Department, Besançon University Hospital, Besançon, France.
  • Chretien ML; Hematology Department, Dijon University Hospital, Dijon, France.
  • Demarquette H; Hematology Department, Dunkerque Hospital, Dunkerque, France.
  • Mohty M; Hematology Department, Saint-Antoine University Hospital, Paris, France.
  • Avet-Loiseau H; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France.
  • Corre J; Unit for Genomics in Myeloma, University Hospital IUC-Oncopole and Toulouse Cancer Research Center-Oncopole, Toulouse University, INSERM UMR1037, Toulouse, France.
Blood ; 141(11): 1308-1315, 2023 03 16.
Article en En | MEDLINE | ID: mdl-36375118

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Mieloma Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Blood Año: 2023 Tipo del documento: Article